S&P Pharmaceuticals SPDR (XPH)

$47.91 0.07 (0.15%)

20:00 EDT XPH Stock Quote Delayed 30 Minutes

Bret Kenwell

7 Pharmaceutical Stocks to Buy for 2021 and Beyond

By Bret Kenwell, InvestorPlace Contributor Nov 17, 2020

Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives. With them, we can solve Covid-19.

Apellis is Outperforming the Pharmaceutical Sector

Use Johnson & Johnson for Quick Income

Collect on the Pharmaceutical Boom With Eli Lilly

More Articles

Volume:

Previous Close -

Market Cap 2.35M

PE Ratio -

EPS -

Volume (Avg. Vol.) 17,073

Day's Range 47.89 - 48.45

52-Week Range 43.61 - 56.32

Dividend & Yield 0.24 (0.50%)

XPH Stock Predictions, Articles, and S&P Pharmaceuticals SPDR News

From InvestorPlace
From the Web

3 Healthcare ETFs to Sell Amid Political Headwinds

By Todd Shriber, InvestorPlace Contributor Apr 23, 2019

While the rest of the market continues upward, the healthcare sector -- and healthcare ETFs -- continue to struggle.

5 Best-Performing Sector ETFs of July

By Zacks Investment Research Aug 2, 2018

We have highlighted sector ETFs that witnessed handsome gains last month and could be better plays in the months ahead should the trends prevail. Compare Broker....

7 Best Healthcare ETFs for the Rest of 2018

By Todd Shriber, InvestorPlace Contributor Mar 8, 2018

Some of the best healthcare ETFs to buy are more "traditional", while others focus on very specific areas of the industry. These seven healthcare ETFs should deliver for investors over the remainder of 2018.

What Lies in Store for Pharma ETFs?

By Zacks Investment Research Nov 27, 2017

Pharma stocks have done well this year; what lies ahead?

When You Exit the Market, Don’t Let The Door Hit You On Your Way Out

By Gary Gordon, President, Pacific Park Financial May 18, 2016

You cannot make this stuff up. The median stock in the S&P 500 has never been more overvalued on these key metrics. Now's the time for caution...

3 “Happy New Year” ETFs to Buy for Huge Growth

By Johnson Research Group Dec 22, 2015

Unwarranted bearishness and strong technicals make these three ETFs good bets for the New Year.

The Cost Of Saving The Economy: $1.7 Billion Per Hour Every Hour

From Talk Markets Aug 20, 2021

the Fed has bought $4 trillion bonds in the past 18 months, twice the amount the US spent on War in Afghanistan past 20 years as it, and other global central banks, have spent $834 million every hour buying bonds since COVID.

3 Pharma Stocks with Tremendous Growth Potential

From StockNews.com Jun 30, 2021

Growing optimism over the pharmaceutical industry’s growth prospects amid the COVID-19 pandemic has bolstered the performance of certain dominant pharma players. As pharma companies continue to invest heavily in drug development to capitalize on rising demand from an aging population, they are well positioned to achieve extraordinary growth going forward. Given the tremendous growth potential of Johnson & Johnson (JNJ), Pfizer (PFE), and Bristol-Myers Squibb (BMY), we think these stocks could be solid bets now. So, let’s take a closer look at these names.

The 2 Best Pharma Stocks to Buy on Dips

From Talk Markets Jun 23, 2021

Because the COVID-19 pandemic is under control in most major economies, the hype surrounding vaccine producers is gradually tapering off.

The 2 Best Pharma Stocks to Buy on Dips

From StockNews.com Jun 22, 2021

The aging population in much of the world, including the United States, is driving increased demand for healthcare solutions. And continuing innovations therein is why we believe that it could be wise to scoop up shares of well-positioned pharma companies Johnson & Johnson (JNJ) and Pfizer (PFE) on every dip. Read on.

3 Top Pharma Stocks to Buy This Month

From Talk Markets Jun 9, 2021

In 2020, pharmaceutical stocks came to the forefront as healthcare companies were searching for treatments for COVID-19.

Pharma ETFs in Focus Post Q1 Earnings

From Talk Markets May 12, 2021

The slew of Q1 results has led to mixed trading in pharma ETFs over the past month. Here are those in detail.